secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2021-12-23T23:59:59+00:00
Accession:  0001193125-21-366182
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma extends CFO Brian Drazba's retirement to June 30, 2022
-----------------------------------------------------------------

- CFO Brian Drazba's employment extended to June 30, 2022, under amended retirement agreement.
- Mr. Drazba eligible for $414,140 severance (12 months' base salary) if he leaves other than for cause.
- Outstanding stock options will vest as if employment continued through first anniversary of retirement date; exercise period extended to one year post-retirement.
- Accelerated vesting and exercise benefits contingent on signing release and complying with restrictive covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312521366182/0001193125-21-366182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312521366182/d275307d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-366182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer